Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 1.00 |
| ▸ | DPP4 | P27487 | 1/20 | 0.89 |
| ▸ | CD38 | P28907 | 1/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 4/20 | 0.49 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | P4HB | P07237 | 2/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.49 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 1/20 | 0.49 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | ALPL | P05186 | 1/20 | 0.49 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.49 |
| ▸ | ALPI | P09923 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanin SCHEMBL6139364 | 1.00 | F2 (1.00) | F2DPP4CD38KDM4EGAA | |
| Cyanin SCHEMBL31019317 | 1.00 | F2 (1.00) | F2DPP4CD38KDM4EGAA | |
| Cyanin SCHEMBL29453487 | 1.00 | F2 (1.00) | F2DPP4CD38KDM4EGAA | |
| Cyanin SCHEMBL6138846 | 1.00 | F2 (1.00) | F2DPP4CD38KDM4EGAA | |
| Cyanin SCHEMBL9234904 | 1.00 | F2 (1.00) | F2DPP4CD38KDM4EGAA | |
| SCHEMBL6139043 | 1.00 | F2 (1.00) | F2DPP4CD38KDM4EGAA | |
| Cyanin SCHEMBL29762024 | 0.99 | F2 (0.98) | F2DPP4CD38KDM4EGAA | |
| SCHEMBL30217528 | 0.94 | F2 (0.89) | F2DPP4CD38KDM4EGAA | |
| SCHEMBL4740208 | 0.94 | F2 (0.89) | F2DPP4CD38KDM4EGAA | |
| Kuromanin SCHEMBL409593 | 0.94 | CD38 (1.00) | F2DPP4CD38KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025047832-A1 | SKIN COSMETIC COMPOSITION CONTAINING BOTRYOCOCCENE AS ACTIVE INGREDIENT | フィコケミー株式会社 | 2025-03-06 | — | — | WO | claimed |
| US-12011496-B2 | Topical macqui berry formulation | Tracie Martyn International, Inc. (US) | 2024-06-18 | — | — | US | claimed |
| WO-2024118307-A1 | TREATMENT OF AUTISM SPECTRUM DISORDERS WITH ERGOTHIONEINE, SELENONEINE, OR COMBINATIONS THEREOF | Autism Therapeutics Inc. (US) | 2024-06-06 | — | — | WO | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| WO-2023167248-A1 | NEW PEST CONTROL METHOD TARGETING RESPIRATORY ORGAN FORMING MECHANISM OF PESTS | 国立研究開発法人産業技術総合研究所 | 2023-09-07 | — | — | WO | claimed |
| CN-115901991-A | Extraction and determination method of anthocyanin in xylem of cinnabar plum stem | 北京林业大学 | 2023-04-04 | — | — | CN | claimed |
| US-20220279829-A1 | Use of Anthocyanin-Anionic Polysaccharide Complex for Preventing or Treating Influenza Virus A Infection | JBKLAB CO., LTD. (KR) | 2022-09-08 | — | — | US | claimed |
| US-20220249675-A1 | Composition for Preventing, Ameliorating, or Treating Gastritis or peptic Ulcer Comprising Anthocyanin-Negatively Charged Polysaccharide Complex as Active Ingredient | JBKLAB CO., LTD. (KR) | 2022-08-11 | — | — | US | claimed |
| CN-114456218-A | Blueberry anthocyanin, preparation method thereof and application of blueberry anthocyanin in preparation of functional food for resisting acrylamide neurotoxicity | 中国农业大学 | 2022-05-10 | — | — | CN | claimed |
| US-20220105017-A1 | TOPICAL MACQUI BERRY FORMULATION | TRACIE MARTYN INT INC (US) | 2022-04-07 | — | — | US | claimed |
| EP-1808169-A2 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | Proteotech Inc. (US) | 2007-07-18 | — | — | EP | claimed |
| US-6818234-B1 | Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation | ACCESS BUSINESS GROUP INTERNATIONAL LLC | 2004-11-16 | — | — | US | claimed |
| US-20040152760-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTAMED, INC. | 2004-08-05 | — | — | US | claimed |
| JP-2003532634-A | — | — | 2003-11-05 | — | — | JP | claimed |
| EP-1244435-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND $g(a)-SYNUCLEIN FIBRIL DISEASES | Proteotech Inc. (US) | 2002-10-02 | — | — | EP | claimed |
| WO-2002024212-A1 | CHOLESTEROL IN BLOOD-LOWERING COMPOSITION AND ITS COMPLEX, AND METHOD FOR PREPARING THEM | ULTIMATE LIFE TECHNOLOGY CO., LTD. (KR) | 2002-03-28 | — | — | WO | claimed |
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTAMED, INC. | 2001-11-29 | — | — | US | claimed |
| WO-2001049281-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND α-SYNUCLEIN FIBRIL DISEASES | PROTEOTECH, INC. (US) | 2001-07-12 | — | — | WO | claimed |
| WO-1983001117-A1 | FERTILITY INDICATOR SYSTEM CONTAINING ANTHOCYANIN PIGMENT | GOLDMAN, DOROTHEE, F., E. | 1983-03-31 | — | — | WO | claimed |
| US-4358288-A | Fertility indicator system containing anthocyanin pigment | GOLDMAN, DOROTHEE F.E. | 1982-11-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | SNCA, PARK7, HTT | F2 4377/4885DPP4 3385/4885CD38 3135/4885 |
| US-20040152760-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | SNCA, PARK7, HTT | F2 4377/4885DPP4 3385/4885CD38 3135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.